Companies Dominating the Immunoprotein Diagnostic Testing Landscape
- Thermofisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- Abcam plc
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin S.p.A
- Enzo Biochem
- Ortho Clinical Diagnostics
- KSL Diagnostics Inc.
- KSL Beutner Laboratories
Browse Key Market Insights with Data Illustration:
In the News
- In July 2022, KSL Beutner Laboratories launched the first indirect immunofluorescence (IIF) serum blood test to market in the United States, which positively identified laminin 332, an antigen associated with mucosal pemphigoid (MMP), a chronic and debilitating autoimmune disease.
- In April 2022, KSL Diagnostics, Inc launched the first antibody test that detects an individual's immune response to COVID-19 and assesses the risk of infection if exposed. The COVID-19 Immunity Index can help monitor protection against the COVID-19 virus with a simple blood test.
